| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 331 |
| 1 | ETANERCEPT | 267 |
| 2 | RISANKIZUMAB-RZAA | 178 |
| 3 | ERGOCALCIFEROL | 139 |
| 4 | INTERFERON BETA-1A | 138 |
| 5 | OMEPRAZOLE MAGNESIUM | 130 |
| 6 | UPADACITINIB | 128 |
| 7 | ASPIRIN | 122 |
| 8 | ASPIRIN 325 MG | 117 |
| 9 | ASPIRIN 81 MG | 117 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ECULIZUMAB-AEEB | 1 | 0.0909 |
| 1 | ANTIHEMOPHILIC FACTOR (RECOMBINANT), GLYCOPEGYLATED-EXEI | 1 | 0.0130 |
| 2 | BUTALBITAL, ASPIRIN, AND CAFFEINE | 1 | 0.0058 |
| 3 | INFLIXIMAB-DYYB | 20 | 0.0058 |
| 4 | ERGOCALCIFEROL | 139 | 0.0047 |
| 5 | ANORECTAL OINTMENT | 1 | 0.0046 |
| 6 | GOLIMUMAB | 49 | 0.0039 |
| 7 | ADALIMUMAB-AACF | 1 | 0.0030 |
| 8 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 8 | 0.0029 |
| 9 | ATROPINE INJECTION, 2 MG | 4 | 0.0027 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 482 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 252 |
| 2 | Interleukin-23 Antagonist [EPC] | 216 |
| 3 | Benzodiazepine [EPC] | 166 |
| 4 | Corticosteroid [EPC] | 158 |
| 5 | Proton Pump Inhibitor [EPC] | 145 |
| 6 | Kinase Inhibitor [EPC] | 141 |
| 7 | Interferon beta [EPC] | 139 |
| 8 | Provitamin D2 Compound [EPC] | 139 |
| 9 | Janus Kinase Inhibitor [EPC] | 130 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 12 | 0.0174 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 13 | 0.0063 |
| 2 | Provitamin D2 Compound [EPC] | 139 | 0.0047 |
| 3 | Classical Complement Pathway Inhibitor [EPC] | 1 | 0.0031 |
| 4 | Interleukin-36 Receptor Antagonist [EPC] | 1 | 0.0025 |
| 5 | Adrenocorticotropic Hormone [EPC] | 2 | 0.0022 |
| 6 | Interleukin-23 Antagonist [EPC] | 216 | 0.0021 |
| 7 | Medium-chain Triglyceride [EPC] | 1 | 0.0018 |
| 8 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 2 | 0.0016 |
| 9 | Interleukin-17 Receptor A Antagonist [EPC] | 3 | 0.0015 |